PD 124,895 and PD 124,966, two new antitumor antibiotics.
- 1 January 1986
- journal article
- research article
- Published by Japan Antibiotics Research Association in The Journal of Antibiotics
- Vol. 39 (12) , 1651-1656
- https://doi.org/10.7164/antibiotics.39.1651
Abstract
The isolation and characterization of the title antibiotics, which are produced by the same Streptomyces sp., is described. The potent antitumor agent, PD 124, 895, is an analog of hydroxyelactocin (PD 114,721). PD 124,966 is a new member of the depsipeptide family of antibiotics.This publication has 4 references indexed in Scilit:
- Structural study of a new antitumor antibiotic, kazusamycin.The Journal of Antibiotics, 1985
- Novel antitumor antibiotics, CI-940 (PD 114,720) and PD 114,721. Taxonomy, fermentation and biological activity.The Journal of Antibiotics, 1985
- Empedopeptin (BMY-28117), a new depsipeptide antibiotic. II. Structure determination.The Journal of Antibiotics, 1984
- Studies on SF-1902 A2-A5, minor components of SF-1902 (globomycin).The Journal of Antibiotics, 1981